US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history.

Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel

Teva Pharmaceutical announced a proposal to acquire all of the outstanding shares of Mylan in a transaction valued at $40 billion

Roche has acquired CAPP Medical, a genomics research company

Mylan has made a proposal to acquire Perrigo in a cash-and-stock transaction that would create a diversified, global pharmaceutical leader

Horizon Pharma will acquire all of the issued and outstanding shares of Hyperion’s common stock for $46.00 per share in cash or approximately $1.1 billion

OptumRx and Catamaran have agreed to combine

Teva and Auspex Pharmaceuticals have entered into a definitive merger agreement

Mumbai, India: March 25, 2015 – Sun Pharmaceutical Industries Ltd., begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.

Janssen Pharmaceuticals has acquired XO1 Limited